CA2460402A1 - Preservation of non embryonic cells from non hematopoietic tissues - Google Patents
Preservation of non embryonic cells from non hematopoietic tissues Download PDFInfo
- Publication number
- CA2460402A1 CA2460402A1 CA002460402A CA2460402A CA2460402A1 CA 2460402 A1 CA2460402 A1 CA 2460402A1 CA 002460402 A CA002460402 A CA 002460402A CA 2460402 A CA2460402 A CA 2460402A CA 2460402 A1 CA2460402 A1 CA 2460402A1
- Authority
- CA
- Canada
- Prior art keywords
- cells
- cell
- adipose tissue
- stem cells
- adipocyte
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004321 preservation Methods 0.000 title description 7
- 230000003394 haemopoietic effect Effects 0.000 title description 4
- 210000002308 embryonic cell Anatomy 0.000 title 1
- 210000004027 cell Anatomy 0.000 claims abstract description 255
- 210000000130 stem cell Anatomy 0.000 claims abstract description 164
- 210000000577 adipose tissue Anatomy 0.000 claims abstract description 108
- 238000000034 method Methods 0.000 claims abstract description 88
- 239000011159 matrix material Substances 0.000 claims abstract description 60
- 230000008569 process Effects 0.000 claims abstract description 50
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 24
- 238000010257 thawing Methods 0.000 claims abstract description 18
- 239000002537 cosmetic Substances 0.000 claims abstract description 6
- 210000001519 tissue Anatomy 0.000 claims description 78
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 47
- 239000000463 material Substances 0.000 claims description 45
- 210000001789 adipocyte Anatomy 0.000 claims description 34
- 238000005138 cryopreservation Methods 0.000 claims description 31
- 238000012545 processing Methods 0.000 claims description 29
- 238000003860 storage Methods 0.000 claims description 29
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 239000002577 cryoprotective agent Substances 0.000 claims description 17
- 210000004369 blood Anatomy 0.000 claims description 16
- 239000008280 blood Substances 0.000 claims description 16
- 238000001816 cooling Methods 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 14
- 238000005406 washing Methods 0.000 claims description 14
- 238000000926 separation method Methods 0.000 claims description 13
- 238000005119 centrifugation Methods 0.000 claims description 12
- 150000002632 lipids Chemical class 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 108060005980 Collagenase Proteins 0.000 claims description 11
- 102000029816 Collagenase Human genes 0.000 claims description 11
- 229960002424 collagenase Drugs 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000012528 membrane Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 230000035899 viability Effects 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 239000000654 additive Substances 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 6
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 230000001413 cellular effect Effects 0.000 claims description 6
- 230000000717 retained effect Effects 0.000 claims description 6
- 239000006285 cell suspension Substances 0.000 claims description 5
- 230000000959 cryoprotective effect Effects 0.000 claims description 5
- 239000000725 suspension Substances 0.000 claims description 5
- 102000009027 Albumins Human genes 0.000 claims description 4
- 108010088751 Albumins Proteins 0.000 claims description 4
- 239000008366 buffered solution Substances 0.000 claims description 4
- 238000001943 fluorescence-activated cell sorting Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 239000007790 solid phase Substances 0.000 claims description 4
- 239000012808 vapor phase Substances 0.000 claims description 4
- 108010053770 Deoxyribonucleases Proteins 0.000 claims description 3
- 102000016911 Deoxyribonucleases Human genes 0.000 claims description 3
- 102000035195 Peptidases Human genes 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- 239000012071 phase Substances 0.000 claims description 3
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims description 3
- 238000009987 spinning Methods 0.000 claims description 3
- 238000010792 warming Methods 0.000 claims description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 2
- 229920001612 Hydroxyethyl starch Polymers 0.000 claims description 2
- 239000004367 Lipase Substances 0.000 claims description 2
- 102000004882 Lipase Human genes 0.000 claims description 2
- 108090001060 Lipase Proteins 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims description 2
- 108090000526 Papain Proteins 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- 102000004142 Trypsin Human genes 0.000 claims description 2
- 108090000631 Trypsin Proteins 0.000 claims description 2
- 239000011324 bead Substances 0.000 claims description 2
- 238000005188 flotation Methods 0.000 claims description 2
- 229940050526 hydroxyethylstarch Drugs 0.000 claims description 2
- 235000019421 lipase Nutrition 0.000 claims description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 2
- 229940055729 papain Drugs 0.000 claims description 2
- 235000019834 papain Nutrition 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 235000013772 propylene glycol Nutrition 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 239000012588 trypsin Substances 0.000 claims description 2
- 229960001322 trypsin Drugs 0.000 claims description 2
- 230000002338 cryopreservative effect Effects 0.000 claims 3
- 208000007536 Thrombosis Diseases 0.000 claims 1
- 230000003028 elevating effect Effects 0.000 claims 1
- 210000001778 pluripotent stem cell Anatomy 0.000 claims 1
- 238000010008 shearing Methods 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 210000002808 connective tissue Anatomy 0.000 abstract description 18
- 238000007443 liposuction Methods 0.000 description 29
- 210000001185 bone marrow Anatomy 0.000 description 17
- 238000011084 recovery Methods 0.000 description 15
- 239000012530 fluid Substances 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 238000013459 approach Methods 0.000 description 11
- 230000008439 repair process Effects 0.000 description 11
- 230000004069 differentiation Effects 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- 230000007246 mechanism Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 210000000988 bone and bone Anatomy 0.000 description 8
- 210000004700 fetal blood Anatomy 0.000 description 8
- 230000036512 infertility Effects 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 238000007710 freezing Methods 0.000 description 7
- 230000008014 freezing Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000002699 waste material Substances 0.000 description 7
- 238000003556 assay Methods 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 210000001671 embryonic stem cell Anatomy 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000007689 inspection Methods 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 230000037361 pathway Effects 0.000 description 6
- 239000008188 pellet Substances 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 230000000735 allogeneic effect Effects 0.000 description 5
- 210000002798 bone marrow cell Anatomy 0.000 description 5
- 238000004113 cell culture Methods 0.000 description 5
- 230000003833 cell viability Effects 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 5
- 238000002513 implantation Methods 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 230000002062 proliferating effect Effects 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 230000003466 anti-cipated effect Effects 0.000 description 4
- 238000010322 bone marrow transplantation Methods 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000000644 isotonic solution Substances 0.000 description 4
- FVVLHONNBARESJ-NTOWJWGLSA-H magnesium;potassium;trisodium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;acetate;tetrachloride;nonahydrate Chemical compound O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[Mg+2].[Cl-].[Cl-].[Cl-].[Cl-].[K+].CC([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O FVVLHONNBARESJ-NTOWJWGLSA-H 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 238000001000 micrograph Methods 0.000 description 4
- 208000010125 myocardial infarction Diseases 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 238000003211 trypan blue cell staining Methods 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 229920002457 flexible plastic Polymers 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000001582 osteoblastic effect Effects 0.000 description 3
- 230000002188 osteogenic effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000003104 tissue culture media Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010031243 Osteogenesis imperfecta Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 230000002648 chondrogenic effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000001066 destructive effect Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 210000003981 ectoderm Anatomy 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 238000001415 gene therapy Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 210000003716 mesoderm Anatomy 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 210000004663 osteoprogenitor cell Anatomy 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 210000000229 preadipocyte Anatomy 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 description 2
- WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010007710 Cartilage injury Diseases 0.000 description 1
- 235000016936 Dendrocalamus strictus Nutrition 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 208000009329 Graft vs Host Disease Diseases 0.000 description 1
- 208000028782 Hereditary disease Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 108010052014 Liberase Proteins 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 208000029725 Metabolic bone disease Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000906034 Orthops Species 0.000 description 1
- 206010049088 Osteopenia Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010043276 Teratoma Diseases 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003409 anti-rejection Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000012237 artificial material Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 210000002960 bfu-e Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 229950004398 broxuridine Drugs 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 238000013354 cell banking Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000023715 cellular developmental process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000009816 chondrogenic differentiation Effects 0.000 description 1
- 238000011281 clinical therapy Methods 0.000 description 1
- 238000009643 clonogenic assay Methods 0.000 description 1
- 231100000096 clonogenic assay Toxicity 0.000 description 1
- 230000003021 clonogenic effect Effects 0.000 description 1
- 239000000515 collagen sponge Substances 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Natural products CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 231100000294 dose-dependent toxicity Toxicity 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 210000001900 endoderm Anatomy 0.000 description 1
- 210000004039 endoderm cell Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 208000024908 graft versus host disease Diseases 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000013394 immunophenotyping Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- GRPSNTXTTSBKGW-BVGHQBMWSA-J magnesium;potassium;sodium;(3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol;triacetate;chloride Chemical compound [Na+].[Mg+2].[Cl-].[K+].CC([O-])=O.CC([O-])=O.CC([O-])=O.OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O GRPSNTXTTSBKGW-BVGHQBMWSA-J 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000005063 microvascular endothelium Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000001964 muscle biopsy Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000004070 myogenic differentiation Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000004031 neuronal differentiation Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000008723 osmotic stress Effects 0.000 description 1
- 230000004840 osteo-chondrogenic effect Effects 0.000 description 1
- 201000010459 osteogenesis imperfecta type 3 Diseases 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 238000004091 panning Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000003668 pericyte Anatomy 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 229940021222 peritoneal dialysis isotonic solution Drugs 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 238000007390 skin biopsy Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000013190 sterility testing Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004781 supercooling Methods 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000006459 vascular development Effects 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/16—Physical preservation processes
- A01N1/162—Temperature processes, e.g. following predefined temperature changes over time
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32207001P | 2001-09-14 | 2001-09-14 | |
| US60/322,070 | 2001-09-14 | ||
| US10/242,094 | 2002-09-12 | ||
| US10/242,094 US20030054331A1 (en) | 2001-09-14 | 2002-09-12 | Preservation of non embryonic cells from non hematopoietic tissues |
| PCT/US2002/029207 WO2003024215A1 (en) | 2001-09-14 | 2002-09-13 | Preservation of non embryonic cells from non hematopoietic tissues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2460402A1 true CA2460402A1 (en) | 2003-03-27 |
Family
ID=26934818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002460402A Abandoned CA2460402A1 (en) | 2001-09-14 | 2002-09-13 | Preservation of non embryonic cells from non hematopoietic tissues |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20030054331A1 (https=) |
| EP (1) | EP1427279A1 (https=) |
| JP (2) | JP2005502712A (https=) |
| KR (1) | KR100779812B1 (https=) |
| CN (1) | CN1585602A (https=) |
| AU (1) | AU2002326901B2 (https=) |
| CA (1) | CA2460402A1 (https=) |
| WO (1) | WO2003024215A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004091637A3 (en) * | 2003-04-07 | 2004-11-25 | Neostem Inc | System capable of treating and defining various diseases using stem cells |
Families Citing this family (148)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001288468A1 (en) * | 2000-08-28 | 2002-03-13 | Ebox.Com, Inc. | A high security wireless key for asynchronous delivery drop boxes |
| US7585670B2 (en) | 2001-12-07 | 2009-09-08 | Cytori Therapeutics, Inc. | Automated methods for isolating and using clinically safe adipose derived regenerative cells |
| KR100930139B1 (ko) | 2001-12-07 | 2009-12-07 | 사이토리 테라퓨틱스, 인크. | 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한시스템 및 방법 |
| US7595043B2 (en) | 2001-12-07 | 2009-09-29 | Cytori Therapeutics, Inc. | Method for processing and using adipose-derived stem cells |
| US7514075B2 (en) | 2001-12-07 | 2009-04-07 | Cytori Therapeutics, Inc. | Systems and methods for separating and concentrating adipose derived stem cells from tissue |
| US7771716B2 (en) | 2001-12-07 | 2010-08-10 | Cytori Therapeutics, Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
| US20050048035A1 (en) | 2001-12-07 | 2005-03-03 | Fraser John K. | Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| US20050095228A1 (en) | 2001-12-07 | 2005-05-05 | Fraser John K. | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
| US7651684B2 (en) | 2001-12-07 | 2010-01-26 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| US9597395B2 (en) | 2001-12-07 | 2017-03-21 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| KR20040094910A (ko) * | 2002-04-03 | 2004-11-10 | 아르테셀 사이언스, 인크. | 개선된 지방세포 분화된 지방 유래 성체 줄기세포 및 이의용도 |
| US7992725B2 (en) | 2002-05-03 | 2011-08-09 | Biomet Biologics, Llc | Buoy suspension fractionation system |
| US7832566B2 (en) | 2002-05-24 | 2010-11-16 | Biomet Biologics, Llc | Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles |
| US20030205538A1 (en) | 2002-05-03 | 2003-11-06 | Randel Dorian | Methods and apparatus for isolating platelets from blood |
| WO2003099412A1 (en) | 2002-05-24 | 2003-12-04 | Biomet Manufacturing Corp. | Apparatus and method for separating and concentrating fluids containing multiple components |
| US20060278588A1 (en) | 2002-05-24 | 2006-12-14 | Woodell-May Jennifer E | Apparatus and method for separating and concentrating fluids containing multiple components |
| US7845499B2 (en) | 2002-05-24 | 2010-12-07 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| MXPA05009044A (es) * | 2003-02-20 | 2006-03-17 | Macropore Biosurgery Inc | Metodos para utilizar celulas derivadas de tejido adiposo en el tratamiento de condiciones cardiovasculares. |
| US20040193274A1 (en) * | 2003-03-28 | 2004-09-30 | Trieu Hai H. | Materials and methods for augmenting and/or repairing intervertebral discs |
| WO2005012480A2 (en) * | 2003-06-25 | 2005-02-10 | Macropore Biosurgery Inc. | Systems and methods for separating and concentrating regenerative cells from tissue |
| ES2633604T3 (es) * | 2003-09-17 | 2017-09-22 | Cytori Therapeutics, Inc. | Métodos para usar células regenerativas derivadas de adiposo en el tratamiento de una enfermedad vascular periférica |
| US7840646B2 (en) * | 2003-10-08 | 2010-11-23 | Yahoo! Inc. | Learned upload time estimate module |
| JP2007508018A (ja) | 2003-10-08 | 2007-04-05 | べト−ステム インコーポレイテッド | 新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット |
| WO2005095583A1 (en) * | 2004-03-03 | 2005-10-13 | Life-Sciences Ag | Large scale storage of viable somatic stem and/or progenitor cells |
| WO2005095581A1 (en) * | 2004-03-19 | 2005-10-13 | Macropore Biosurgery Inc. | Cell carrier and cell carrier containment devices containing regenerative cells |
| WO2006014159A2 (en) * | 2004-07-01 | 2006-02-09 | Macropore Biosurgery Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
| DK1778834T5 (da) | 2004-07-01 | 2012-01-09 | Cytori Therapeutics Inc | Fremgangsmåder til anvendelse af regenerative celler i behandlingen af renale sygdomme og lidelser |
| US20060045872A1 (en) | 2004-08-25 | 2006-03-02 | Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco | Use of adipose tissue-derived stromal stem cells in treating fistula |
| WO2006062989A1 (en) * | 2004-12-07 | 2006-06-15 | Bacterin International, Inc. | Three-dimensional cell culsture system |
| WO2006074075A2 (en) * | 2004-12-30 | 2006-07-13 | Primegen Biotech, Llc | Adipose-derived stem cells for tissue regeneration and wound healing |
| US7866485B2 (en) | 2005-02-07 | 2011-01-11 | Hanuman, Llc | Apparatus and method for preparing platelet rich plasma and concentrates thereof |
| US7708152B2 (en) | 2005-02-07 | 2010-05-04 | Hanuman Llc | Method and apparatus for preparing platelet rich plasma and concentrates thereof |
| ES2426941T3 (es) * | 2005-02-07 | 2013-10-25 | Hanuman Llc | Aparato y procedimiento de concentrados de plasma rico en plaquetas |
| US20070032774A1 (en) * | 2005-05-17 | 2007-02-08 | Clifford Glade | Container for transporting blood and blood products |
| JP4907908B2 (ja) * | 2005-06-29 | 2012-04-04 | ルネサスエレクトロニクス株式会社 | 駆動回路及び表示装置 |
| KR101536239B1 (ko) | 2005-09-23 | 2015-07-13 | 셀레릭스, 에스.엘. | 면역조절활성을 갖는 세포 개체군, 분리 방법 및 용도 |
| DK1957633T3 (en) * | 2005-10-13 | 2014-03-17 | Anthrogenesis Corp | Immunomodulation USING PLACE SPEECH STEM CELLS |
| US20070227547A1 (en) * | 2006-02-14 | 2007-10-04 | Sdgi Holdings, Inc. | Treatment of the vertebral column |
| US20070213718A1 (en) * | 2006-02-14 | 2007-09-13 | Sdgi Holdings, Inc. | Treatment of the vertebral column |
| US20070213717A1 (en) * | 2006-02-14 | 2007-09-13 | Sdgi Holdings, Inc. | Biological fusion in the vertebral column |
| US7520888B2 (en) * | 2006-02-14 | 2009-04-21 | Warsaw Orthopedic, Inc. | Treatment of the vertebral column |
| US8567609B2 (en) | 2006-05-25 | 2013-10-29 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| WO2007139551A1 (en) * | 2006-05-30 | 2007-12-06 | Cytori Therapeutics, Inc. | Systems and methods for manipulation of regenerative cells from adipose tissue |
| KR100803576B1 (ko) * | 2006-06-14 | 2008-02-15 | 주식회사 인피트론 | 지방줄기세포 및 지방세포를 포함한 이식용 조성물 |
| WO2008013863A2 (en) * | 2006-07-26 | 2008-01-31 | Cytori Therapeutics, Inc. | Generation of adipose tissue and adipocytes |
| US8034014B2 (en) | 2007-03-06 | 2011-10-11 | Biomet Biologics, Llc | Angiogenesis initation and growth |
| US8328024B2 (en) | 2007-04-12 | 2012-12-11 | Hanuman, Llc | Buoy suspension fractionation system |
| JP5479319B2 (ja) | 2007-04-12 | 2014-04-23 | バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー | ブイ式懸濁液分画システム |
| US20090192528A1 (en) * | 2008-01-29 | 2009-07-30 | Biomet Biologics, Inc. | Method and device for hernia repair |
| EP2567692B1 (en) | 2008-02-27 | 2016-04-06 | Biomet Biologics, LLC | Use of a device for obtaining interleukin-1 receptor antagonist rich solutions |
| WO2009111338A1 (en) | 2008-02-29 | 2009-09-11 | Biomet Manufacturing Corp. | A system and process for separating a material |
| WO2009115581A2 (en) * | 2008-03-19 | 2009-09-24 | Cryo-Save Ag | Improved cryopreservation of adipose tissue for the isolation of mesenchymal stem cells |
| US8012077B2 (en) | 2008-05-23 | 2011-09-06 | Biomet Biologics, Llc | Blood separating device |
| EP3124601A1 (en) * | 2008-08-14 | 2017-02-01 | Mesoblast International Sàrl | Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions |
| WO2010021993A1 (en) * | 2008-08-19 | 2010-02-25 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease |
| AU2009201915C1 (en) * | 2008-08-22 | 2015-02-26 | Regeneus Ltd | Therapeutic methods |
| AU2011247866B9 (en) * | 2008-08-22 | 2014-02-13 | Regeneus Ltd. | Allogeneic therapeutic methods using adipose tissue-derived cell suspensions |
| US8187475B2 (en) | 2009-03-06 | 2012-05-29 | Biomet Biologics, Llc | Method and apparatus for producing autologous thrombin |
| US8313954B2 (en) | 2009-04-03 | 2012-11-20 | Biomet Biologics, Llc | All-in-one means of separating blood components |
| AU2010242780B2 (en) * | 2009-05-01 | 2016-04-21 | Puregraft Llc | Systems, methods and compositions for optimizing tissue and cell enriched grafts |
| US20100291534A1 (en) * | 2009-05-12 | 2010-11-18 | National Central University | Methods and Systems for Isolating, Ex Vivo Expanding and Harvesting Hematopoietic Stem Cells |
| US9011800B2 (en) | 2009-07-16 | 2015-04-21 | Biomet Biologics, Llc | Method and apparatus for separating biological materials |
| US8591391B2 (en) | 2010-04-12 | 2013-11-26 | Biomet Biologics, Llc | Method and apparatus for separating a material |
| US8883210B1 (en) | 2010-05-14 | 2014-11-11 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| EP2593117B1 (en) | 2010-07-12 | 2019-03-20 | University of Southern California | Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same |
| WO2012048276A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
| AU2011343513B2 (en) * | 2010-12-16 | 2016-07-14 | Ingeneron, Inc. | Methods and apparatus for enhanced recovery of cells and of cell-enriched matrix from tissue samples |
| US8877489B2 (en) | 2011-12-05 | 2014-11-04 | California Institute Of Technology | Ultrathin parylene-C semipermeable membranes for biomedical applications |
| US10478206B2 (en) | 2011-04-29 | 2019-11-19 | University Of Southern California | Instruments and methods for the implantation of cell-seeded substrates |
| US9109198B2 (en) * | 2011-04-29 | 2015-08-18 | General Electric Company | Automated systems and methods for isolating regenerative cells from adipose tissue |
| ES2722207T3 (es) | 2011-04-29 | 2019-08-08 | Univ Southern California | Procedimientos para la crioconservación de células epiteliales de pigmento retiniano derivadas de citoblastos crecidas sobre un sustrato polimérico |
| US8834928B1 (en) | 2011-05-16 | 2014-09-16 | Musculoskeletal Transplant Foundation | Tissue-derived tissugenic implants, and methods of fabricating and using same |
| EP2744892B1 (en) | 2011-09-23 | 2019-03-20 | Cell Ideas Pty Ltd. | Therapeutics using adipose cells and cell secretions |
| US10154664B2 (en) * | 2011-10-06 | 2018-12-18 | David K Moscatello | Systems and methods for the digestion of adipose tissue samples obtained from a client for cryopreservation |
| US8932805B1 (en) | 2011-10-31 | 2015-01-13 | BioDlogics, LLC | Birth tissue material and method of preparation |
| WO2013070899A1 (en) | 2011-11-08 | 2013-05-16 | Auxocell Laboratories, Inc. | Systems and methods for processing cells |
| ES2377796B8 (es) * | 2011-11-25 | 2012-12-28 | Banc De Sang I Teixits | Procedimiento para preparar productos de terapia celular o ingeniería tisular. |
| US9248013B2 (en) | 2011-12-05 | 2016-02-02 | California Institute Of Technology | 3-Dimensional parylene scaffold cage |
| EP2788008A4 (en) * | 2011-12-07 | 2015-08-26 | Cytovera Inc | PROCESS AND DEVICE FOR SAMPLE PROCESSING |
| BR112014017081A8 (pt) * | 2012-01-17 | 2017-07-04 | Nico Corp | sistema de recuperação e preservação de amostra de tecido; sistema de preservação de tecido; e sistema de resfriamento |
| WO2013184978A2 (en) * | 2012-06-07 | 2013-12-12 | David Moscatello | Compositions and methods for collecting, washing, cryopreserving, recovering and return of lipoaspirates to physician for autologous adipose transfer procedures |
| CN104508122A (zh) * | 2012-06-20 | 2015-04-08 | 赛璐拉有限公司 | 用于处理细胞群体的材料和方法 |
| CN102907416B (zh) * | 2012-08-01 | 2016-08-03 | 西比曼生物科技（上海）有限公司 | 一种可维持细胞活性的组织冻存液 |
| US9642956B2 (en) | 2012-08-27 | 2017-05-09 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
| US9950035B2 (en) | 2013-03-15 | 2018-04-24 | Biomet Biologics, Llc | Methods and non-immunogenic compositions for treating inflammatory disorders |
| US10143725B2 (en) | 2013-03-15 | 2018-12-04 | Biomet Biologics, Llc | Treatment of pain using protein solutions |
| US10208095B2 (en) | 2013-03-15 | 2019-02-19 | Biomet Manufacturing, Llc | Methods for making cytokine compositions from tissues using non-centrifugal methods |
| HUE056073T2 (hu) * | 2013-03-15 | 2022-01-28 | Genzyme Corp | Magas denzitású sejtbanki tárolási eljárások |
| US9895418B2 (en) | 2013-03-15 | 2018-02-20 | Biomet Biologics, Llc | Treatment of peripheral vascular disease using protein solutions |
| US20140271589A1 (en) | 2013-03-15 | 2014-09-18 | Biomet Biologics, Llc | Treatment of collagen defects using protein solutions |
| CN120796168A (zh) | 2013-06-11 | 2025-10-17 | 哈佛学院校长同事会 | SC-β细胞以及用于产生其的组合物和方法 |
| US9580678B2 (en) | 2013-06-21 | 2017-02-28 | The Regents Of The University Of California | Microfluidic tumor tissue dissociation device |
| SG11201600133TA (en) * | 2013-07-10 | 2016-02-26 | Agency Science Tech & Res | Method for isolating stromal vascular fraction |
| US20150037436A1 (en) | 2013-07-30 | 2015-02-05 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
| EP3052943B1 (en) * | 2013-10-04 | 2019-11-20 | Cell Ideas Pty Ltd. | Biomarkers for cell therapy |
| WO2015073913A1 (en) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
| JP2017506097A (ja) | 2014-02-05 | 2017-03-02 | マフィン・インコーポレイテッドＭｕｆｆｉｎ Ｉｎｃｏｒｐｏｒａｔｅｄ | 区画された低温保存容器およびその使用 |
| WO2015148704A1 (en) | 2014-03-25 | 2015-10-01 | Terumo Bct, Inc. | Passive replacement of media |
| US9993748B2 (en) | 2014-08-11 | 2018-06-12 | Auxocell Laboratories, Inc. | Centrifuge clip and method |
| USD748462S1 (en) | 2014-08-11 | 2016-02-02 | Auxocell Laboratories, Inc. | Centrifuge clip |
| EP3198006B1 (en) | 2014-09-26 | 2021-03-24 | Terumo BCT, Inc. | Scheduled feed |
| US10201573B1 (en) | 2014-10-27 | 2019-02-12 | Brahm Holdings, Llc | Human birth tissue material composition and methods for the treatment of damage associated with a cerebral vascular accident |
| US10265438B1 (en) | 2014-11-03 | 2019-04-23 | BioDlogics, LLC | Methods and compositions for the repair and replacement of connective tissue |
| US9713810B2 (en) | 2015-03-30 | 2017-07-25 | Biomet Biologics, Llc | Cell washing plunger using centrifugal force |
| FR3035407B1 (fr) | 2015-04-23 | 2022-06-17 | Francais Du Sang Ets | Procede de conservation de cellules, tissus ou organes en hypothermie |
| US9757721B2 (en) | 2015-05-11 | 2017-09-12 | Biomet Biologics, Llc | Cell washing plunger using centrifugal force |
| CA2986702C (en) | 2015-05-21 | 2023-04-04 | David Wang | Modified demineralized cortical bone fibers |
| WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
| US10912864B2 (en) | 2015-07-24 | 2021-02-09 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
| US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
| US12551509B2 (en) | 2015-11-18 | 2026-02-17 | Lucina Patent Holdco, Llc | Acellular regenerative products and methods of their manufacture |
| EP3381458B1 (en) * | 2015-11-24 | 2023-06-07 | Rohto Pharmaceutical Co., Ltd. | Therapeutic agent for liver disease containing stromal cells derived from adipose tissue and method for producing the same |
| CN105613484B (zh) * | 2015-12-16 | 2018-10-26 | 华南生物医药研究院 | 巨核祖细胞冻存液及其应用 |
| US10722540B1 (en) | 2016-02-01 | 2020-07-28 | The Regents Of The University Of California | Microfluidic device and method for shear stress-induced transformation of cells |
| WO2017141831A1 (ja) * | 2016-02-16 | 2017-08-24 | ロート製薬株式会社 | 脂肪組織由来間質細胞を含む虚血性疾患治療剤およびその製造方法 |
| GB201604304D0 (en) | 2016-03-14 | 2016-04-27 | Tigenix S A U | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease |
| US11965175B2 (en) | 2016-05-25 | 2024-04-23 | Terumo Bct, Inc. | Cell expansion |
| US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
| US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
| CN109564231B (zh) | 2016-06-08 | 2023-01-06 | 加利福尼亚大学董事会 | 用于处理组织和细胞的方法和装置 |
| JP2019146487A (ja) * | 2016-06-16 | 2019-09-05 | 株式会社ワンビシアーカイブズ | クライオボックス運搬および保管用容器 |
| CN106465710B (zh) * | 2016-08-19 | 2020-04-14 | 杭州易文赛生物技术有限公司 | 脂肪组织冻存液及脂肪组织冻存方法 |
| US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
| US12234441B2 (en) | 2017-03-31 | 2025-02-25 | Terumo Bct, Inc. | Cell expansion |
| CN117247899A (zh) | 2017-03-31 | 2023-12-19 | 泰尔茂比司特公司 | 细胞扩增 |
| CN108925548A (zh) * | 2017-05-24 | 2018-12-04 | 西比曼生物科技（香港）有限公司 | 一种冻存细胞制剂及细胞复苏方式 |
| CN111051499A (zh) | 2017-05-24 | 2020-04-21 | 哈佛学院校长同事会 | 卫星细胞及其组合物和生产方法 |
| CN108402032B (zh) * | 2018-03-14 | 2021-01-05 | 重庆奥纳思生物科技有限公司 | 一种脐带血干细胞储藏方法 |
| CN108477141B (zh) * | 2018-03-14 | 2021-01-05 | 重庆奥纳思生物科技有限公司 | 一种脐带血干细胞医用储藏箱 |
| ES2738956B2 (es) * | 2018-07-26 | 2022-01-17 | Disentropic S L | Dispositivo para el procesado del tejido graso y sus usos |
| CA3110745A1 (en) | 2018-09-07 | 2020-03-12 | University Of Southern California | Cryopreservation of cell-seeded substrates and related methods |
| KR102146379B1 (ko) * | 2019-03-04 | 2020-08-21 | 고려대학교 산학협력단 | 조직의 급속동결 보관장치 및 조직의 급속동결 보관방법 |
| US11697799B2 (en) | 2019-04-15 | 2023-07-11 | Ossium Health, Inc. | System and method for extraction and cryopreservation of bone marrow |
| WO2021007180A1 (en) | 2019-07-05 | 2021-01-14 | Case Western Reserve University | Priming media and methods for stem cell culture and therapy |
| KR20220150272A (ko) * | 2020-03-05 | 2022-11-10 | 세키스이 메디칼 가부시키가이샤 | 세포 함유액용 보존 용기 및 보존액 |
| EP4181675A4 (en) | 2020-07-18 | 2024-04-24 | Ossium Health, Inc. | PERMEATION OF WHOLE VERTEBRATE BODIES WITH A CRYOPRETECTIVE AGENT USING VACUUM-ASSISTED DIFFUSION |
| US12426594B2 (en) | 2020-09-24 | 2025-09-30 | Everest Medical Innovation GmbH | Cryoprotective compositions and methods for protection of a surgical site during cryosurgery |
| US12453805B2 (en) | 2020-09-24 | 2025-10-28 | Everest Medical Innovation GmbH | Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery |
| CA3195653A1 (en) | 2020-10-14 | 2022-04-21 | Ossium Health, Inc. | Systems and methods for extraction and cryopreservation of bone marrow |
| DE102020127787B4 (de) * | 2020-10-22 | 2025-08-14 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein | Verfahren und Kryokonservierungsvorrichtung zur Kryokonservierung einer Vielzahl von Zellverbänden aus biologischen Zellen |
| WO2022133282A1 (en) | 2020-12-18 | 2022-06-23 | Ossium Health, Inc. | Methods of cell therapies |
| EP4314244B1 (en) | 2021-03-23 | 2025-07-23 | Terumo BCT, Inc. | Cell capture and expansion |
| US20250188417A1 (en) | 2021-04-11 | 2025-06-12 | President And Fellows Of Harvard College | Cardiomyocytes and compositions and methods for producing the same |
| CN114916534A (zh) * | 2022-02-11 | 2022-08-19 | 南京艾拓生命科技有限公司 | 一种间充质干细胞活性因子包装结构 |
| US12209689B2 (en) | 2022-02-28 | 2025-01-28 | Terumo Kabushiki Kaisha | Multiple-tube pinch valve assembly |
| USD1099116S1 (en) | 2022-09-01 | 2025-10-21 | Terumo Bct, Inc. | Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458678A (en) * | 1981-10-26 | 1984-07-10 | Massachusetts Institute Of Technology | Cell-seeding procedures involving fibrous lattices |
| US5372945A (en) * | 1985-06-06 | 1994-12-13 | Alchas; Paul G. | Device and method for collecting and processing fat tissue and procuring microvessel endothelial cells to produce endothelial cell product |
| US5035708A (en) * | 1985-06-06 | 1991-07-30 | Thomas Jefferson University | Endothelial cell procurement and deposition kit |
| US5312380A (en) * | 1985-06-06 | 1994-05-17 | Thomas Jefferson University | Endothelial cell procurement and deposition kit |
| US4820626A (en) * | 1985-06-06 | 1989-04-11 | Thomas Jefferson University | Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself |
| US5436135A (en) * | 1985-09-02 | 1995-07-25 | Pasteur Merieux Serums Et Vaccins | New preparation of placenta collagen, their extraction method and their applications |
| US4963489A (en) * | 1987-04-14 | 1990-10-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
| US5158867A (en) * | 1987-08-21 | 1992-10-27 | Cryolife Inc. | Method for cryopreserving blood vessels |
| US4883755A (en) * | 1987-10-28 | 1989-11-28 | Thomas Jefferson University | Method of reendothelializing vascular linings |
| US4834703A (en) * | 1987-11-23 | 1989-05-30 | Dubrul Will R | Liposuction filter and lipoplasty device |
| US5092883A (en) * | 1988-12-28 | 1992-03-03 | Eppley Barry L | Method for promoting soft connective tissue growth and repair in mammals |
| ATE120355T1 (de) * | 1990-02-09 | 1995-04-15 | Univ Jefferson | Vorrichtung zur sammlung und verarbeitung von fetten geweben zur herstellung von endothel- zellprodukt. |
| JPH0413700A (ja) * | 1990-05-08 | 1992-01-17 | Katsuya Takasu | コラーゲンの分離方法 |
| US5641622A (en) * | 1990-09-13 | 1997-06-24 | Baxter International Inc. | Continuous centrifugation process for the separation of biological components from heterogeneous cell populations |
| US5837539A (en) * | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
| US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5226914A (en) * | 1990-11-16 | 1993-07-13 | Caplan Arnold I | Method for treating connective tissue disorders |
| NZ242533A (en) * | 1991-05-03 | 1995-05-26 | Becton Dickinson Co | Device for collecting and processing fat tissue; vessel with rinsing and digesting chamber, drain chamber and isolation chamber |
| US5261612A (en) * | 1991-10-09 | 1993-11-16 | Newman-Ftaiha, Inc. | Method and apparatus for extracting injectable collagen from adipose tissue |
| US5316942A (en) * | 1993-06-16 | 1994-05-31 | Battelle Memorial Institute | Process for the production of low-cost soluble high-molecular weight collagen |
| US5409833A (en) * | 1993-07-01 | 1995-04-25 | Baxter International Inc. | Microvessel cell isolation apparatus |
| US5470307A (en) * | 1994-03-16 | 1995-11-28 | Lindall; Arnold W. | Catheter system for controllably releasing a therapeutic agent at a remote tissue site |
| JPH07255469A (ja) * | 1994-03-17 | 1995-10-09 | Kurabo Ind Ltd | 動物細胞の凍結保存液 |
| WO1996001641A1 (de) * | 1994-07-08 | 1996-01-25 | Sulzer Medizinaltechnik Ag | Verfahren zur herstellung von implantationsmaterialien |
| JPH0892001A (ja) * | 1994-09-26 | 1996-04-09 | Asahi Medical Co Ltd | 細胞集団の保存方法 |
| DE4439480C1 (de) * | 1994-11-08 | 1996-06-05 | Asta Medica Ag | Verwendung von D,L- alpha-Liponsäure und/oder ihren Enantiomeren, und/oder ihren Derivaten als Zusatz bei Erythrozyten-Flüssigkonserven für homologe und autologe Erythrozyten-Konzentrate und als Zusatz bei Erythrozyten-Kryokonserven für homologe und autologe Erythrozytenkonzentrate |
| DE19519887C1 (de) * | 1995-05-31 | 1996-06-13 | Henkel Kgaa | Verfahren zur Epoxidierung olefinisch ungesättigter Verbindungen |
| US5783408A (en) * | 1995-06-07 | 1998-07-21 | Hamilton; Bradford S. | Method for screening potential anti-obesity agents |
| US6200606B1 (en) * | 1996-01-16 | 2001-03-13 | Depuy Orthopaedics, Inc. | Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration |
| JP4609807B2 (ja) * | 1996-03-28 | 2011-01-12 | 雪印乳業株式会社 | 骨強化用医薬、飲食品及び飼料 |
| JPH1017310A (ja) * | 1996-07-03 | 1998-01-20 | Ehime Pref Gov | コラーゲン、ヒドロキシアパタイトの製造方法及びその生成物 |
| US5980887A (en) * | 1996-11-08 | 1999-11-09 | St. Elizabeth's Medical Center Of Boston | Methods for enhancing angiogenesis with endothelial progenitor cells |
| US5830741A (en) * | 1996-12-06 | 1998-11-03 | Boehringer Mannheim Corporation | Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease |
| US5786207A (en) * | 1997-05-28 | 1998-07-28 | University Of Pittsburgh | Tissue dissociating system and method |
| JPH114682A (ja) * | 1997-06-16 | 1999-01-12 | Asahi Medical Co Ltd | 有核細胞保存方法、有核細胞保存用組成物及び有核細胞分離方法 |
| EP1108011A2 (en) * | 1998-06-08 | 2001-06-20 | Osiris Therapeutics, Inc. | In vitro maintenance of hematopoietic stem cells |
| US6090121A (en) * | 1998-12-02 | 2000-07-18 | Weber; Paul J. | Highly flexible, reinforced swan neck liposuction cannulas |
| KR100979664B1 (ko) * | 1999-03-10 | 2010-09-02 | 유니버시티 오브 피츠버그 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | 지방 유래 간세포 및 격자 |
| US6777231B1 (en) * | 1999-03-10 | 2004-08-17 | The Regents Of The University Of California | Adipose-derived stem cells and lattices |
| US6316247B1 (en) * | 1999-06-15 | 2001-11-13 | University Of Pittsburgh | System and method for refining liposuctioned adipose tissue |
-
2002
- 2002-09-12 US US10/242,094 patent/US20030054331A1/en not_active Abandoned
- 2002-09-13 KR KR1020047003710A patent/KR100779812B1/ko not_active Expired - Fee Related
- 2002-09-13 CA CA002460402A patent/CA2460402A1/en not_active Abandoned
- 2002-09-13 WO PCT/US2002/029207 patent/WO2003024215A1/en not_active Ceased
- 2002-09-13 EP EP02761654A patent/EP1427279A1/en not_active Withdrawn
- 2002-09-13 CN CNA028226283A patent/CN1585602A/zh active Pending
- 2002-09-13 JP JP2003528119A patent/JP2005502712A/ja active Pending
- 2002-09-13 AU AU2002326901A patent/AU2002326901B2/en not_active Ceased
-
2009
- 2009-08-18 JP JP2009189198A patent/JP2009269930A/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004091637A3 (en) * | 2003-04-07 | 2004-11-25 | Neostem Inc | System capable of treating and defining various diseases using stem cells |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005502712A (ja) | 2005-01-27 |
| WO2003024215A1 (en) | 2003-03-27 |
| EP1427279A1 (en) | 2004-06-16 |
| US20030054331A1 (en) | 2003-03-20 |
| KR100779812B1 (ko) | 2007-11-28 |
| AU2002326901B2 (en) | 2007-11-01 |
| JP2009269930A (ja) | 2009-11-19 |
| CN1585602A (zh) | 2005-02-23 |
| KR20040044912A (ko) | 2004-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002326901B2 (en) | Preservation of non embryonic cells from non hematopoietic tissues | |
| AU2002326901A1 (en) | Preservation of non embryonic cells from non hematopoietic tissues | |
| AU2009227022B2 (en) | Improved cryopreservation of adipose tissue for the isolation of mesenchymal stem cells | |
| JP7401865B2 (ja) | 機能的な間葉系幹細胞の富化集団を得る方法、それによって得られる細胞、およびその細胞を含む組成物 | |
| US20130023049A1 (en) | Viable cells from frozen umbilical cord tissue | |
| CN103074298B (zh) | 一种人脂肪间充质干细胞库及其构建方法 | |
| CN106465710B (zh) | 脂肪组织冻存液及脂肪组织冻存方法 | |
| WO2009120996A1 (en) | Mehtod, system, and apparatus for hypothermic collection, storage, transport and banking of birth tissue | |
| KR20220004086A (ko) | 골수의 추출 및 저온보존을 위한 시스템 및 방법 | |
| CN101889079A (zh) | 适于临床应用的人胎盘间质细胞库的建立方法 | |
| KR20100084620A (ko) | 조직 재생을 위한 세포 조성물 | |
| CN115094025A (zh) | 子宫内膜基质干细胞的制备方法 | |
| JP6851602B2 (ja) | ヒト幹細胞の保存液、ヒト幹細胞懸濁液およびヒト幹細胞の保存方法 | |
| CN106614527B (zh) | 用于脂肪源性干细胞临床即用型活性保存方法 | |
| WO2022140613A1 (en) | Methods and compositions for the treatment of perianal fistula in crohn's disease | |
| CN111647551A (zh) | 同一胎盘绒毛小叶组织来源细胞的提取及保存方法 | |
| CN107849532A (zh) | 冷冻间充质细胞的制备方法和移植用治疗材料的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |